CAFs‐derived exosomal miR‐3126‐5p accelerated NSCLC progression via inhibiting KLF13 expression, which transcriptionally activated SH2B1 to promote its interaction with IRS1, thereby promoting PI3K/AKT pathway‐mediated glycolysis. The gene discussed is SH2B1; the disease is non-small cell lung carcinoma.